BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19231337)

  • 1. A mechanistic investigation into how long-term resynchronization therapy confers ongoing cardiac functional benefits and improved exercise capacity.
    Schlosshan D; Barker D; Lewis N; Pepper C; Tan LB
    Am J Cardiol; 2009 Mar; 103(5):701-8. PubMed ID: 19231337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops.
    Steendijk P; Tulner SA; Bax JJ; Oemrawsingh PV; Bleeker GB; van Erven L; Putter H; Verwey HF; van der Wall EE; Schalij MJ
    Circulation; 2006 Mar; 113(10):1295-304. PubMed ID: 16520415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure.
    Chwyczko T; Sterliński M; Maciag A; Firek B; Labecka A; Jankowska A; Kośmicki M; Kowalik I; Malczewska B; Szwed H
    Kardiol Pol; 2008 Apr; 66(4):406-12; discussion 413-4. PubMed ID: 18473269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure.
    Laveneziana P; O'Donnell DE; Ofir D; Agostoni P; Padeletti L; Ricciardi G; Palange P; Duranti R; Scano G
    J Appl Physiol (1985); 2009 May; 106(5):1574-83. PubMed ID: 19246658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity.
    Piepoli MF; Villani GQ; Corrà U; Aschieri D; Rusticali G
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):701-8. PubMed ID: 18507542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
    Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incremental benefit of rate-adaptive pacing on exercise performance during cardiac resynchronization therapy.
    Tse HF; Siu CW; Lee KL; Fan K; Chan HW; Tang MO; Tsang V; Lee SW; Lau CP
    J Am Coll Cardiol; 2005 Dec; 46(12):2292-7. PubMed ID: 16360061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing patient benefit from cardiac resynchronization therapy with the addition of structured exercise training: a randomized controlled study.
    Patwala AY; Woods PR; Sharp L; Goldspink DF; Tan LB; Wright DJ
    J Am Coll Cardiol; 2009 Jun; 53(25):2332-9. PubMed ID: 19539142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac functional reserve is diminished in growth hormone-deficient adults.
    Moisey R; Orme S; Barker D; Lewis N; Sharp L; Clements RE; Goldspink DF; Tan LB
    Cardiovasc Ther; 2009; 27(1):34-41. PubMed ID: 19207478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: a preliminary study.
    Lenarczyk R; Kowalski O; Kukulski T; Pruszkowska-Skrzep P; Sokal A; Szulik M; Zielińska T; Kowalczyk J; Pluta S; Sredniawa B; Musialik-Łydka A; Kalarus Z
    Int J Cardiol; 2009 Mar; 133(1):87-94. PubMed ID: 18242737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients.
    Seifert M; Schlegl M; Hoersch W; Fleck E; Doelger A; Stockburger M; Butter C
    Int J Cardiol; 2007 Sep; 121(1):68-73. PubMed ID: 17582527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of all-day physical activity on ventilatory perfusion coupling in patients undergoing cardiac resynchronization therapy.
    Berger T; Zwick RH; Poelzl G; Hoertnagl H; Pachinger O; Stuhlinger M; Roithinger FX; Hintringer F
    Cardiology; 2008; 111(1):68-74. PubMed ID: 18239396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure.
    Sims DB; Mignatti A; Colombo PC; Uriel N; Garcia LI; Ehlert FA; Jorde UP
    Europace; 2011 Oct; 13(10):1459-63. PubMed ID: 21551475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
    Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L
    Eur Heart J; 2006 Aug; 27(16):1928-32. PubMed ID: 16782715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony.
    Williams LK; Ellery S; Patel K; Leyva F; Bleasdale RA; Phan TT; Stegemann B; Paul V; Steendijk P; Frenneaux M
    Circulation; 2009 Oct; 120(17):1687-94. PubMed ID: 19822812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of rate-adaptive atrial pacing versus ventricular backup pacing on exercise capacity in patients with left ventricular dysfunction.
    Passman R; Banthia S; Galvez D; Sheldon T; Kadish A
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):1-6. PubMed ID: 19140906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.